Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia

doi:10.3748/wjg.v20.i15.4421

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 15

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6771)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

405

WORD

293

HTML

3661

Figures (1-3)

196

Tables (1-2)

156

Sum=4711

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

969

Download

1091

Sum=2060

Apr 21, 2014 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Research Report

World J Gastroenterol. Apr 21, 2014; 20(15): 4421-4427
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4421

Full Size Figure Download Figure

Figure 3 Relationship between the expression of CCL2 and overall survival time in gastric cancer patients. Patients with high CCL2 expression had a poor overall survival [50.6 mo (95%CI: 44.44-56.93) vs 64.6 mo (95%CI: 60.27-68.94), P = 0.013].

Citation: Tao LL, Shi SJ, Chen LB, Huang GC. Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia. World J Gastroenterol 2014; 20(15): 4421-4427
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4421.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4421